Article Details
Retrieved on: 2021-07-20 02:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Meissa Vaccines (“Meissa”), a biotechnology company developing ... using the company's proprietary AttenuBlock ™ synthetic biology platform, which ...
Article found on: www.thedailytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here